Population
Patients with end-stage renal disease and diabetic nephropathy (general discussion)
Design
Review
Authors
Loading...
Genetic complexity in diabetic ESRD leaves actionable loci unidentified; extends heritability insights but requires validation before therapeutic application.
End-stage renal disease has a complex genetic component, and future therapeutic development will require the application of genetic and genomic tools.
Schelling et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: